1. Home
  2. PHGE vs DTSS Comparison

PHGE vs DTSS Comparison

Compare PHGE & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • DTSS
  • Stock Information
  • Founded
  • PHGE 2015
  • DTSS 2014
  • Country
  • PHGE Israel
  • DTSS China
  • Employees
  • PHGE N/A
  • DTSS N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • PHGE Health Care
  • DTSS Technology
  • Exchange
  • PHGE Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • PHGE 13.3M
  • DTSS 14.2M
  • IPO Year
  • PHGE N/A
  • DTSS N/A
  • Fundamental
  • Price
  • PHGE $0.59
  • DTSS $1.91
  • Analyst Decision
  • PHGE Strong Buy
  • DTSS
  • Analyst Count
  • PHGE 2
  • DTSS 0
  • Target Price
  • PHGE $23.00
  • DTSS N/A
  • AVG Volume (30 Days)
  • PHGE 200.7K
  • DTSS 43.2K
  • Earning Date
  • PHGE 05-19-2025
  • DTSS 05-12-2025
  • Dividend Yield
  • PHGE N/A
  • DTSS N/A
  • EPS Growth
  • PHGE N/A
  • DTSS N/A
  • EPS
  • PHGE N/A
  • DTSS N/A
  • Revenue
  • PHGE N/A
  • DTSS $47,284,153.00
  • Revenue This Year
  • PHGE N/A
  • DTSS N/A
  • Revenue Next Year
  • PHGE N/A
  • DTSS N/A
  • P/E Ratio
  • PHGE N/A
  • DTSS N/A
  • Revenue Growth
  • PHGE N/A
  • DTSS 117.51
  • 52 Week Low
  • PHGE $0.48
  • DTSS $1.63
  • 52 Week High
  • PHGE $4.99
  • DTSS $8.56
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 51.14
  • DTSS 43.52
  • Support Level
  • PHGE $0.52
  • DTSS $1.84
  • Resistance Level
  • PHGE $0.57
  • DTSS $1.94
  • Average True Range (ATR)
  • PHGE 0.05
  • DTSS 0.12
  • MACD
  • PHGE 0.01
  • DTSS 0.00
  • Stochastic Oscillator
  • PHGE 62.83
  • DTSS 53.85

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: